The global chronic hepatitis B treatment market is witnessing significant growth. This trend can be attributed to a rising of factors, including an increasing population, advanced diagnostic capabilities, and growing awareness about the disease. The market is further driven by developments in treatment strategies, such as antiviral therapies. A ke